Thermoresponsive 2,3-dicarboxy hyaluronan/phenanthriplatin nanogels for the treatment of ovarian cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F70883521%3A28610%2F24%3A63588998" target="_blank" >RIV/70883521:28610/24:63588998 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Thermoresponsive 2,3-dicarboxy hyaluronan/phenanthriplatin nanogels for the treatment of ovarian cancer
Original language description
Sequential regioselective oxidation of HA, which essentially triples the amount of carboxylic groups available for drug binding, can be used in tandem with other selective modifications to prepare thermoresponsive functional derivatives of HA. Prepared DCH-PhPt nanogel combines both thermoresponsivity and high drug carrier capacity into a highly promising drug delivery system exhibiting significant potential in cancer therapy, particularly for ovarian cancer and its cisplatin-resistant variants.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30404 - Biomaterials (as related to medical implants, devices, sensors)
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů